Introduction
Multiple sclerosis (MS) is a progressive autoimmune disease causing disability and premature mortality. Pathologically MS is characterized by inflammation, demyelination and neurodegeneration in the central nervous system (CNS). Several disorders in these disease groups affect brain and the nervous system in MS, such as cardio-and cerebrovascular diseases, hypertension and diabetes. (7) There is a risk for premature mortality in MS (8, 9) and the major cause of death are infections.
It is increasingly recognized that the common causes of death observed in general population are present also in MS, such as cardiovascular causes and stroke (8) (9) (10) (11) . At the same time findings regarding the prevalence of several vascular comorbidities in MS are conflicting (12) .
During the follow-up death in MS occurred in 5.9% (n 70, 34 women and 36 men). The main cause of death was infections (n 38, 54.3%). Other specific causes in the circulatory diseases group (n 5, 7.1%) were one case of acute myocardial infarct, four cases of ischemic stroke and one case of subarachnoid haemorrhage. Causes in other disease groups were respiratory insufficiency (n 6, 8.6%), cancer (n 3, 4.3%) and intoxication (n 2, 2.9%). The rest of the death causes represented other causes of death (n 16, 22.9%).
The mean survival time in MS was 82.4 years compared to 85.6 years in the age and gender matched control population, difference was statistically significant (KM log rank p <0.001), KM curve shown in Figure 1 The number of MS, age-and gender matched control cases and OR's for specific circulatory diseases diagnoses are presented in Table 2 . An almost 50% greater risk for ischemic cerebral infarct in MS (n 25), OR 1.49 (95% CI 1.03-2.35), was statistically significant. A statistically significant and over two-fold risk was observed also for other strokes (n 9) including both subarachnoid and intracerebral haemorrhages: OR 2.5 (1.24-5.06). Acute myocardial infarct (n 18, 1.85%) showed no increased risk in MS, OR was 1.49 (0.91-2.43). Diagnoses with other cerebrovascular diseases by code I67 (n 9) and sequelae of cerebrovascular disease I69 (n 18) may overlap the acute stroke diagnoses why they were assessed separately. Respective OR's were high, 2.5 (1.24-5.06) and 1.73 (1.06-2.83).
Ischemic stroke (cerebral infarct, I63) was confirmed either as a comorbid diagnosis (n 21) or an immediate cause of death (n 4). Case ascertainment was based on findings in CT scan or MRI in 92% (23/25 cases), location was mainly parietal in middle artery region (n 11), posterior (n 6) and subcortical (n 6). Female to male ratio was 0.79 (11/13 cases The number of MS, age-and gender matched control cases and OR's for a number of acute and chronic infections are presented in Table 4 . with detailed results. The coincident risk for the hospital treated infections showed an increased risk for urinary, respiratory and periodontal infections in MS.
Discussion
The lower mean survival time of 82.4 years in MS compared to 85.6 years in the control population was statistically significant. However, life expectancy was reduced much less than in earlier studies showing 6-7 years shorter life expectancy in MS (8, 9, 18) . This supports improved survival in patient cohorts from the era of disease modifying therapies and is in line with the recent study from Norway showing a near normal standardised mortality ratio in the patient cohort monitored from 1997 to 2012 (18) .
The high mortality of cerebrovascular diseases in the Finnish general population (19) was here shown to concern also the MS population. Result supports the Danish study (5) and corroborates survival disadvantage reported for cerebrovascular diseases among MS patients. (10-13) Survival disadvantage related to circulatory disease comorbidity was significant in our study. The mean survival time was lower for MS cases with any circulatory diseases related diagnosis in ICD-10 I06-I71 group, 79.5 years, in comparison with the 85.4 years in MS patients without it. The specific risk for the common risk factors for these diseases, such as hypertension, hyperlipidaemia or cardiac disorders and arrhythmias, were low also in our MS population (20) along with other risk factors for ischemic stroke, except for type 1 diabetes.
MS patients were followed up during a 9-year period in 2004 Strength of our study is the public health care system, where health care is available for all Finnish citizen and an equal treatment practice is followed. The national and hospital registers in Finland base on personalized identification code and are regarded reliable. The administrative health registry covers almost the entire population of the study region and provides objective data avoiding bias related to patient recall. MS is diagnosed and treated by neurologist in central and university hospitals why we believe to have a representative sample of MS patients from a large hospital district. A 10-fold sample of the general non-MS population ensure that study observations reflect general patterns of co-occurrence of health problems among MS patients, which may not be accurate in small clinical samples, due to sampling, or referral biases.
We observed an increased risk for circulatory diseases in MS population as compared to age-and sex matched control population during the follow-up. Evidence that autoimmunity may play an essential role in the pathogenesis of atherosclerosis (21) is supported by reports on increased risk for cerebro-and cardiovascular disorders in several immune-mediated diseases, such as MS (22), rheumatoid arthritis (23, 24) and type 1 diabetes (25) . These results suggest that these inflammatory diseases may share pathological links with cerebrovascular diseases. However, although inflammation is shown to contribute to stroke risk (26) , other typical risk factors may be absent in MS. (25, 27) This view was supported by observations in our data, as other common cerebrovascular risk factors, such as TIA, atrial fibrillation and other arrhythmias, showed no increased risk, nor was there any risk for secondary hypertension, hyperlipidaemia or obesity.
Result differs from observations in rheumatoid arthritis and type 1 diabetes populations, where several common risk factors exist, but corroborates observations in other MS populations where prevalence of diabetes, hypertension, and hyperlipidaemia have been similar to rates in general population. (20) Given the observation of increased risk for stroke, which is diagnosed in hospital, and the low comorbidity for some of the most common vascular disease risk factors, our results are discordant Respiratory infections were the major cause of death and the high rates of acute and chronic respiratory, urinary and periodontal infections were present also in our MS cohort. (8, 11, 28) Acute and chronic infectious diseases are related to risk of stroke (29) and infections may be a specific risk factor in MS population. There is a connection between the immunological and vascular factors (30) , which supports the suggested hypothesis on the shared inflammatory mechanisms in MS and ischemic stroke (31) . 
